z-logo
open-access-imgOpen Access
Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals
Author(s) -
Keisuke Fukuchi,
Kayoko Nanai,
Hiroshi Yuita,
Chikako Maru,
Jun Tsukada,
Masato Ishigami,
Yoko Nagai,
Yoko Nakano,
Chigusa Yoshimura,
Kozo Yoneda,
Masato Amano,
Kensuke Nakamura,
Yoko Oda,
Haruyuki Nishigohri,
S Yamamoto,
Yusuke Ohnishi-Totoki,
Koichiro Inaki,
Hironobu Komori,
Rika Nakano,
Yoshiyuki Kanari,
Atsuko Nishida,
Yumi Matsui,
Satoko Funo,
Sayako Takahashi,
Toshiaki Ohtsuka,
Toshinori Agatsuma
Publication year - 2022
Publication title -
journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.228
H-Index - 54
eISSN - 1687-8469
pISSN - 1687-8450
DOI - 10.1155/2022/3552793
Subject(s) - cd44 , cancer research , antibody , medicine , monoclonal antibody , kinase , cell culture , downregulation and upregulation , integrin , mapk/erk pathway , cell , receptor , immunology , microbiology and biotechnology , biology , biochemistry , genetics , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom